Status: Recruiting
IMRT Alone for Stage IB Nasopharyngeal Carcinoma Without High-Risk Features
This observational study aims to evaluate the efficacy and safety of intensity-modulated radiotherapy (IMRT) alone in patients with stage IB nasopharyngeal carcinoma (NPC) without high-risk features. The primary objective is to determine the therapeutic effectiveness of this approach
Participants needed: 169
Trial details
Age: 18-70Biological sex: AllType: ObservationalSponsor: Qiaojuan GuoUpdated: Jan 29, 2026Locations: 1Duration: 3 Years
Eligibility criteria
Age > 70 years or < 18 years [+9]